SCHEMBL23722360

SCHEMBL23722360

O=C(N[C@@H](Cc1ccc(F)c(F)c1)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O)c1cc2ccccc2[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23722359 0.89 CTSL (0.55)
SCHEMBL23722358 0.89 CTNNB1 (0.50)
SCHEMBL26494064 0.86
SCHEMBL26494057 0.85 CTNNB1 (0.45)
SCHEMBL26453476 0.85 CTSL (0.47)
SCHEMBL26494072 0.85 CTSL (0.43)
SCHEMBL24690765 0.84 CTSL (0.61)
SCHEMBL24961046 0.84 CTSL (0.61)
SCHEMBL23711795 0.83 F2R (0.52)
SCHEMBL24961224 0.83 CTSL (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230138310-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND FRONTIER BIOTECHNOLOGIES INC. (CN) 2023-05-04 US disclosed
US-20230138310-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND FRONTIER BIOTECHNOLOGIES INC. (CN) 2023-05-04 US disclosed
EP-4098653-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-12-07 EP disclosed
WO-2021151265-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND 中国科学院上海药物研究所 2021-08-05 WO disclosed